|
|
[Report]
METABOLOMICS - A MARKET INSIGHT REPORT
Published: 2008/01
|
|
 |
|
|
|
Table of Contents
I. SCOPE AND METHODOLOGY
II. REPORT SYNOPSIS
- 1. Introduction
- Segmentation of Metabolomics Technologies
- 2. Global Market Analysis
- Exhibit 1: Metabolomics (2005-2012) - Global Market Analysis (Current &
Future) in US$ Million (Graphical Representation included)
- Analysis by Metabolomics Technologies
- Combined Systems - The Fastest Growing Technology
- Market Analysis
- Exhibit 2: Combined Systems of Metabolomics (2005-2012) - Global
Market Analysis (Current & Future) by Geographic Region for United States,
Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 3: Combined Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
United States, Europe, Japan, Asia-Pacific, Canada and Rest of World
(Graphical Representation included)
- Hardware Systems - The Fading-out Technology
- Exhibit 4: Hardware Systems of Metabolomics (2005-2012) - Global
Market Analysis (Current & Future) by Geographic Region for United States,
Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 5: Hardware Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
United States, Europe, Japan, Asia-Pacific, Canada and Rest of World
- Software Systems - Ever Growing in Emerging Markets
- Market Analysis
- Exhibit 6: Software Systems of Metabolomics (2005-2012) - Global
Market Analysis (Current & Future) by Geographic Region for United States,
Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 7: Software Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
United States, Europe, Japan, Asia-Pacific, Canada and Rest of World
- Exhibit 8: List of Major Global Companies
- 3. Regional Market Analysis
- North America
- Exhibit 9: Metabolomics (2005-2012) - North American Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Major Companies in North America
- Acadia Pharmaceuticals, Inc. (USA)
- Accelrys, Inc. (USA)
- Agilent Technologies, Inc. (USA)
- Amphora Discovery Corporation (USA)
- Applied Biosystems Group (USA)
- BG Medicine, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Bruker Biosciences Corporation (USA)
- Bruker Daltonics, Inc. (USA)
- Caliper Life Sciences, Inc. (USA)
- Chenomx, Inc. (Canada)
- Cogenics (USA)
- Genego, Inc. (USA)
- Infometrix, Inc. (USA)
- MDS Sciex (Canada)
- Metabolon, Inc. (USA)
- Pharmaceutical Product Development, Inc. (USA)
- Phenomenome Discoveries, Inc. (Canada)
- SiDMAP (USA)
- Thermo Fisher Scientific, Inc. (USA)
- Waters Corporation (USA)
- Analysis by Metabolomics Technologies
- Combined Systems
- Exhibit 10: Combined Systems of Metabolomics (2005-2012) - North
American Market Analysis (Current & Future) by Geographic Region for
United States and Canada in US$ Million (Graphical Representation
included)
- Exhibit 11: Combined Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of North American Market Value by Geographic Region
for United States and Canada (Graphical Representation included)
- Hardware Systems
- Exhibit 12: Hardware Systems of Metabolomics (2005-2012) - North
American Market Analysis (Current & Future) by Geographic Region for
United States and Canada in US$ Million (Graphical Representation
included)
- Exhibit 13: Hardware Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of North American Market Value by Geographic Region
for United States and Canada (Graphical Representation included)
- Software Systems
- Exhibit 14: Software Systems of Metabolomics (2005-2012) - North
American Market Analysis (Current & Future) by Geographic Region for
United States and Canada in US$ Million (Graphical Representation
included)
- Exhibit 15: Software Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of North American Market Value by Geographic Region
for United States and Canada (Graphical Representation included)
- Europe
- Exhibit 16: Metabolomics (2005-2012) - European Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Major Companies in Europe
- Avogadro (France)
- Biocrates Life Sciences AG (Austria)
- Genedata AG (Switzerland)
- Metabometrix Ltd. (UK)
- Metanomics GmbH (Germany)
- Analysis by Metabolomics Technologies
- Combined Systems
- Exhibit 17: Combined Systems of Metabolomics (2005-2012) - European
Market Analysis (Current & Future) by Geographic Region for Germany,
United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and
Rest of Europe in US$ Million (Graphical Representation included)
- Exhibit 18: Combined Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of European Market Value by Geographic Region for
Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland,
Sweden and Rest of Europe (Graphical Representation included)
- Hardware Systems
- Exhibit 19: Hardware Systems of Metabolomics (2005-2012) - European
Market Analysis (Current & Future) by Geographic Region for Germany,
United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and
Rest of Europe in US$ Million (Graphical Representation included)
- Exhibit 20: Hardware Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of European Market Value by Geographic Region for
Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland,
Sweden and Rest of Europe (Graphical Representation included)
- Software Systems
- Exhibit 21: Software Systems of Metabolomics (2005-2012) - European
Market Analysis (Current & Future) by Geographic Region for Germany,
United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and
Rest of Europe in US$ Million (Graphical Representation included)
- Exhibit 22: Software Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of European Market Value by Geographic Region for
Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland,
Sweden and Rest of Europe (Graphical Representation included)
- Asia-Pacific
- Exhibit 23: Metabolomics (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Analysis by Metabolomics Technologies
- Combined Systems
- Exhibit 24: Combined Systems of Metabolomics (2005-2012) -
Asia-Pacific Market Analysis (Current & Future) by Geographic Region for
China, India, Australia and Rest of Asia-Pacific in US$ Million
(Graphical Representation included)
- Exhibit 25: Combined Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of Asia-Pacific Market Value by Geographic Region
for China, India, Australia and Rest of Asia-Pacific (Graphical
Representation included)
- Hardware Systems
- Exhibit 26: Hardware Systems of Metabolomics (2005-2012) -
Asia-Pacific Market Analysis (Current & Future) by Geographic Region for
China, India, Australia and Rest of Asia-Pacific in US$ Million
(Graphical Representation included)
- Exhibit 27: Hardware Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of Asia-Pacific Market Value by Geographic Region
for China, India, Australia and Rest of Asia-Pacific (Graphical
Representation included)
- Software Systems
- Exhibit 28: Software Systems of Metabolomics (2005-2012) -
Asia-Pacific Market Analysis (Current & Future) by Geographic Region for
China, India, Australia and Rest of Asia-Pacific in US$ Million
(Graphical Representation included)
- Exhibit 29: Software Systems of Metabolomics (2006, 2009 and 2012) -
Percentage Breakdown of Asia-Pacific Market Value by Geographic Region
for China, India, Australia and Rest of Asia-Pacific (Graphical
Representation included)
- Rest of World
- Exhibit 30: Metabolomics (2005-2012) - Rest of World Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
III. PRODUCT/TECHNOLOGY RESEARCH
- 1. Introduction
- Backdrop
- Metabolomics - The Definition
- History of Metabolomics
- Metabolomic Profiling
- Separation Methods
- Detection Methods
- Metabolomics Growth Trends - Global Markets
- Exhibit 31: Global Market for Metabolomics: Geographic Regions
(Asia-Pacific, Canada, Europe, Japan and United States) Ranked by
Projected CAGR for 2005 through 2012 (Graphical Representation included)
- Metabolomic Profiling - The Applications
- Toxicity Assessment/Toxicology
- Functional Genomics
- The Human Metabolome Project
- Human Metabolome Database
- Systems Biology Or Integrative Biology
- Biomolecular Networks
- HiRes
- Computer Simulation of Metabolism
- Computer Simulation and the Design of Drugs
- Metabolic Activity Preservation in Lyophilized Human Erythrocytes
- Metabolic flux Ratio Study on Escherichia coli Mutants Using GC-MS Method
- Metabolic profiling
- Metabolomic Profiling - The Technologies
- The LC-MS Technique
- Liquid Chromatographic Radioactivity Detection Techniques
- Structural Genomics in Combination with Metabolic Profiling
- Techniques for Redox Metabolic Profiling
- Metabolomics and Metabonomics
- Metabolism: Metabolites and Metabolome
- Human Nutrition Metabolome
- Metabolomics and Human Health
- Metabolomic Techniques for Genetic Mapping
- Human Metabolic Diagnosis
- Metabolomics in Human Nutrition - Prospects and Experiments
- The Human Nutrition Metabolome Generation
- Pattern-Recognition Methods and Human Nutrition
- Nutrition Evaluation with Pharmacology and Toxicology
- How Metabolites Affect Food
- Metabolomics - Related with other Omics?
- Proteomics, Genomics and Metabolomics
- Functional Genomics
- The Shortcomings/Delays in Functional Genomics Strategies
- Proteomics
- Lipidomics
- The Definition
- The Concept of Lipidomics
- Traditional Analysis of Lipids
- Lipidomics Aids Treatment of CNS Related Diseases
- Glycomics
- Study of Glycobiology - Analytical High-Throughput Technologies
- Transcriptomics
- Arabidopsis Thaliana
- Signal Transduction Process
- Dietary Leucine Excess
- Analysis of Metabolic Pathways
- Types of Metabolic Pathways Databases
- MMCD
- BRENDA
- EMP
- Enzyme Nomenclature Database
- IntEnz
- Kinase Pathway Database
- PhosphaBase
- PRECISE
- TECRDB
- BOCD
- EcoCyc
- KEGG Metabolic Pathways
- Boehringer Mannheim - Biochemical Pathways
- Environmental Metabolomics
- Components for the Study of Metabolomics
- Challenges to Environmental Metabolomics
- Advantages of Metabolomics
- Metabolomics to Probe GM foods
- 2. Metabolomics Technologies
- Sophisticated Analytical Tools Required in Metabolomics
- Scope for Growth in NMR-based Analysis
- The Bottom-up Approach
- Blood as a Central Focus Theme
- An Individualized Approach to Metabolomics
- Growth Trends - Global Biomarker Discovery Technologies
- Exhibit 32: Global Market for Metabolomics: Metabolomics Technologies
(Combined Systems, Hardware Systems and Software Systems ) Ranked by
Projected CAGR for 2005 through 2012 (Graphical Representation included)
- Categorization of Metabolomics Technologies
- Mass Spectrometry
- Applications of Mass Spectrometers
- Protein Detection and Analysis
- Protein Quantitation
- Growth Trend for Combined Systems
- Exhibit 33: Global Market for Combined Systems for Metabolomics:
Geographic Regions (Canada, Europe, Asia-Pacific, Japan and United
States) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Protein Structure Probing
- Space Exploration
- Respiratory Gas Monitoring
- Isotope Ratio Evaluation
- Exposure and Burial Dating
- Growth Trend for Software Systems
- Exhibit 34: Global Market for Software Systems for Metabolomics:
Geographic Regions (Asia-Pacific, Europe, Canada, Japan and United
States) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Trace Gas Analysis
- Pharmacokinetics
- Metabolites Identification and Biomarkers Development
- Nuclear Magnetic Resonance
- Fourier Spectroscopy
- Multi-Dimensional - A Type of FT-NMR
- NMR Based Metabolomics
- Applications of NMR
- Liquid Chromatography/Gas Chromatography
- High Performance Liquid Chromatography
- Lab-on-a-Chip
- Capillary Electrophoresis
- Electrochemical Array
- Application of Electrochemical Array Detection in Metabolomics
- Fourier-Transform Infrared Spectroscopy
- Qualitative Analysis with FT - IR7
- Challenges for Metabolomics
- 3. Metabolomics - A Pharma and Healthcare Perspective
- Metabolomics - Significance of Individual Health
- Need for Awareness of Balanced Diet
- Creation of Basic Structure
- The Creation Stage
- Development of Technologies
- Database Collection on Personalized Metabolites Health
- The Innovation Stage
- Metabolism' s Role in Physical Condition
- Pathways Ideal for Classifying Targets and Techniques
- The Execution Stage
- Execution of Personalized Evaluation Technologies
- Clinical Chemistry and Metabolomics
- Metabolomics in Biomarker Identification
- Metabolite Biomarkers
- Study of Biomarker Metabolites in Oryza Sativa (Rice)
- Limitations of Metabolite Biomarkers
- Personalized Medicine with Metabolomics
- Application of Metabolomics in Transplantation
- Exhibit 35: Reported Frequencies of Organ Transplantations (2006):
Percentage Breakdown of Frequencies for Kidney, Liver, Heart, Pancreas and
Lung Transplantations (Graphical Representation included)
- The Role of Metabolomics in Transplantation of Various Organs
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Metabolomics - In the Process of Drug Discovery
- Metabolomics to Save Time and Cost in Initial Stages
- Distinguishing Varieties of Animal Phenotypes
- Biomarker Detection
- Metabolic Profiling Approach for Biomarker Discovery
- ESI-LC/MS Use in Identifying Biomarkers in Plant Extracts
- Metabolic Profiles and Biomarkers Determine Toxic Drug Effects
IV. MARKET DYNAMICS
- 1. Market Overview
- Global Market Analysis
- Exhibit 36: Metabolomics (2005-2012) - Global Market Analysis (Current
& Future) by Geographic Region for United States, Europe, Japan,
Asia-Pacific, Canada and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 37: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown
of Global Market Value by Geographic Region for United States, Europe,
Japan, Asia-Pacific, Canada and Rest of World (Graphical Representation
included)
- 2. Major Companies in Metabolomics Industry
- Acadia Pharmaceuticals, Inc. (USA)
- Accelrys, Inc. (USA)
- Agilent Technologies, Inc. (USA)
- Amphora Discovery Corporation (USA)
- Applied Biosystems Group (USA)
- Avogadro (France)
- BG Medicine, Inc. (USA)
- Biocrates Life Sciences AG (Austria)
- Bio-Rad Laboratories, Inc. (USA)
- Bruker Biosciences Corporation (USA)
- Caliper Life Sciences, Inc. (USA)
- Chenomx, Inc. (Canada)
- Cogenics (USA)
- Genedata AG (Switzerland)
- Genego, Inc. (USA)
- Human Metabolome Technologies, Inc. (Japan)
- MDS Sciex (Canada)
- Metabolon, Inc. (USA)
- Metabometrix Ltd. (UK)
- Metanomics GmbH (Germany)
- Pharmaceutical Product Development, Inc. (USA)
- Phenomenome Discoveries, Inc. (Canada)
- Shimadzu Corporation (Japan)
- SiDMAP (USA)
- Thermo Fisher Scientific, Inc. (USA)
- Waters Corporation (USA)
- 3. Major Activities in Metabolomics Industry
- UCB Collaborates with BioSeek for Evaluation of Compounds with BioMAP
Systems
- Bruker BioSciences to Acquire Privately Held Bruker BioSpin' s Companies
- Agreement Gives U.S Food and Drug Administration an Access to Genedata
Expressionist Platform
- GeneGo Grants License for Usage of MetaCore to Oregon Health and Science
University (OHSU)' s Facility
- Metabolon Collaborates with US Army Medical Research Institute of
Infectious Diseases
- Metabolon Acquires Cogenics Icoria' s Patented Metabolomics and Toxicity
Technologies
- Bionas Enters into a Service Contract with Solvay Pharmaceuticals
- GeneGo Licenses MetaCore to Biogen Idec
- Chenomx Partners with GeneGo to Provide Metabolomics Data Integration
- ** HMT Explains the Cause of Heterogeneity in Bacillus Subtilis
Populations
- Chenomx Inc. Awarded two Patents for NMR-based Mixture Analysis
Computations
- Nanosys and Bruker Daltonics Collaborate for Research, Development and
Distribution of NALDI(TM)-TOF
- MDS Acquires Entire Stake in MDC
- Agilent Technologies Collaborates with Lipomics for Developing Research
and Diagnostic Biomarker Assays
- BG Medicine and Applied Biosystems Collaborate for Improving Biomarker
Discovery and Development
- AstraZeneca Employs ToxWiz to Determine the Effects of Liver Treatment
Drugs
- Nycomed Acquires ALTANA Pharma AG
- Bayer AG Takes Over Schering AG
- GeneData Collaborates with Serono for Intensifying Analysis on Screening
- GenoLogics' Proteus™ to be Utilized by University of Leuven
- GenoLogics' Geneus Solution to be Utilized for Genomics Research
- Clinical Data Signs Pact with QTC
- Ariadne Grants Pathway Studio License to NCI
- GeneData Enters into Collaboration with Altanta and Introduces Hit
Profiler
- Agilent Signs Agreement with Mass Consortium
- Bruker BioSciences Acquires Stake in Bruker Optics
- GeneData Signs Partnership Agreement with INCA
- Shimadzu Signs Partnership Agreement with Phenomenome
- PathwayStudio® 4.0 of Ariadne Links up with Affymetrix
GeneChip-compatible Applications Program
- Cerep Signs Licensing Agreement with AstraZeneca
- Chenomx Joins Hands with Umetrics to Offer Metabolomics Solutions
- Biocrates signs Alliance Agreement with Altana...
- Bio-Rad Enters into Partnership with Infometrix
- NCTR Establishes Metabolomics Research Center
- Syngenta Acquires Licenses from InforSense
- Clinical Data Initiates Metabolomics Research of Lung Cancer Samples
- CST Extends Agreement with AstraZeneca
- Allied Biosystems Signs Alliance Agreement with MDS and Biocrates
- PrecisionMed Enters into Collaboration with Phenomenome
- PPD Takes Over SurroMed
- 4. Major Product Innovations/Launches in Metabolomics Industry
- Chenomx, Inc. Launches the Upgraded Version of Metabolomics Software
Solution
- Metabolon to Provide mVision™ Service for Biomarker Discovery
- Chenomx Inc. Introduces Metabolic Profiling Services
- Applied Biosystems Launches StepOne™ Real-Time PCR System
- Applied Biosystems Introduces TaqMan®
- Discovery of APG16L1 as a New Gene Related to Crohn' s Disease
- InnoMed Introduces a New Website for Data Transmission
- GenoLogics Discovers Sophisticated Data Management Solutions for Various
Applications
- Phoenix Launches SureSpray Technology
- Bio-Rad Releases Version 7.5 of its KnowItAll Informatics System
- GenoLogics Introduces Geneus™
- Ariadne Introduces Additional Pathway Database for PathwayStudio®
and PathwayExpert™ Software
- Thermo Electron (now Thermo Fisher Scientific) Launches Galileo LIMS v
3.2
- Agilent Launches Liquid Chromatography Column
- Ariadne Introduces New Software for Pathway Analysis
- GeneData Launches Expressionist® Pro 3.0
- Applied Biosystems and MDS Unveil MIDAS™ TRAQ Systems
- Allied Biosystems and MDS Introduce Tempo™, a Liquid
Chromatography System
- GenoLogics Develops OmixLIMS
- GeneGo Incorporates Accord Technology in MetaDrug™
- Applied Biosystems and MDS Sciex Unveil MarkerView™ Software
- Phenomenome Develops Solution for Colorectal Cancer Screening
- Bio-Rad Laboratories Introduces ADMET Databases
- Thermo Electron (now Thermo Fisher Scientific) Introduces LeadStream
ADME/Tox Solution™
- 5. Regional Market Analysis
- A. The United States
- Market Analysis
- Exhibit 38: Metabolomics (2005-2012) - United States Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 39: List of Major Companies in the United States
- Analysis by Metabolomics Technology
- Exhibit 40: Metabolomics (2005-2012) - United States Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 41: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of United States Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems
- B. Europe
- Market Analysis
- Exhibit 42: Metabolomics (2005-2012) - European Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 43: List of Major Companies in Europe
- Analysis by Geographic Region
- Exhibit 44: Metabolomics (2005-2012) - European Market Analysis
(Current & Future) by Geographic Region for Germany, United Kingdom,
Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in
US$ Million (Graphical Representation included)
- Exhibit 45: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of European Market Value by Geographic Region for Germany,
United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and
- Rest of Europe (Graphical Representation included)
- Analysis by Metabolomics Technology
- Exhibit 46: Metabolomics (2005-2012) - European Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 47: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of European Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- European Metabolomics Market by Country
- B1. Germany
- German Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 48: Metabolomics (2005-2012) - German Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 49: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of German Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B2. The United Kingdom
- UK Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 50: Metabolomics (2005-2012) - United Kingdom Market
Analysis (Current & Future) by Metabolomic Technologies for Combined
Systems, Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 51: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of United Kingdom Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B3. Italy
- Italian Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 52: Metabolomics (2005-2012) - Italian Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 53: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Italian Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B4. Belgium
- Belgian Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 54: Metabolomics (2005-2012) - Belgian Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 55: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Belgian Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B5. France
- French Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 56: Metabolomics (2005-2012) - French Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 57: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of French Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B6. Spain
- Spanish Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 58: Metabolomics (2005-2012) - Spanish Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 59: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Spanish Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B7. Switzerland
- Swiss Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 60: Metabolomics (2005-2012) - Swiss Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 61: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Swiss Market Value by Metabolomic Technologies for Combined
Systems, Hardware Systems and Software Systems in US$ Million
- B8. Sweden
- Swedish Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 62: Metabolomics (2005-2012) - Swedish Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 63: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Swedish Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- B9. Rest of Europe
- Rest of Europe Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 64 Metabolomics (2005-2012) - Rest of Europe Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 65: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Rest of Europe Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- C. Japan
- Market Analysis
- Exhibit 66: Metabolomics (2005-2012) - Japanese Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 67: List of Major Companies in Japan
- Analysis by Metabolomics Technology
- Exhibit 68: Metabolomics (2005-2012) - Japanese Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 69: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Japanese Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- D. Asia-Pacific
- Market Analysis
- Exhibit 70: Metabolomics (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 71: List of Major Companies in Asia-Pacific
- Analysis by Geographic Region
- Exhibit 72: Metabolomics (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) by Geographic Region for China, India, Australia and
Rest of Asia-Pacific in US$ Million (Graphical Representation included)
- Exhibit 73: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Asia-Pacific Market Value by Geographic Region for China,
India, Australia and Rest of Asia-Pacific (Graphical Representation
included)
- Analysis by Metabolomics Technology
- Exhibit 74: Metabolomics (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 75: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Asia-Pacific Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
(Graphical Representation included)
- Asia-Pacific Market Analysis by Country
- D1. China
- Chinese Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 76: Metabolomics (2005-2012) - Chinese Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 77: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Chinese Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- D2. India
- Indian Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 78: Metabolomics (2005-2012) - Indian Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 79: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Indian Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- D3. Australia
- Australian Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 80: Metabolomics (2005-2012) - Australian Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 81: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Australian Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
- D4. Rest of Asia-Pacific
- Rest of Asia-Pacific Market Analysis
- Analysis by Metabolomics Technology
- Exhibit 82: Metabolomics (2005-2012) - Rest of Asia-Pacific Market
Analysis (Current & Future) by Metabolomic Technologies for Combined
Systems, Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 83: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Rest of Asia-Pacific Market Value by Metabolomic
Technologies for Combined Systems, Hardware Systems and Software Systems
in US$ Million
- E. Canada
- Market Analysis
- Exhibit 84: Metabolomics (2005-2012) - Canadian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 85: List of Major Companies in Canada
- Analysis by Metabolomics Technology
- Exhibit 86: Metabolomics (2005-2012) - Canadian Market Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 87: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Canadian Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
(Graphical Representation included)
- F. Rest of World
- Market Analysis
- Exhibit 88: Metabolomics (2005-2012) - Rest of World Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 89: List of Major Companies in Rest of World
- Analysis by Metabolomics Technology
- Exhibit 90: Metabolomics (2005-2012) - Rest of World Analysis
(Current & Future) by Metabolomic Technologies for Combined Systems,
Hardware Systems and Software Systems in US$ Million (Graphical
Representation included)
- Exhibit 91: Metabolomics (2006, 2009 and 2012) - Percentage
Breakdown of Rest of World Market Value by Metabolomic Technologies for
Combined Systems, Hardware Systems and Software Systems in US$ Million
(Graphical Representation included)
- 6. Metabolomics - The Industry Outlook
V. CORPORATE DIRECTORY
|
|
|
|
|
|
|
[Report]
METABOLOMICS - A MARKET INSIGHT REPORT
Published: 2008/01
|
Published by : RI Technologies  |
|
|
Price:
|
Product Code : RIT63059 |
|
|
Please inform me when related publications are released
|
|
|
View Cart
